Literature DB >> 8005248

Local antibodies against Pneumocystis carinii in bronchoalveolar lavage fluid.

A L Laursen1, B N Jensen, P L Andersen.   

Abstract

Pneumocystis carinii pneumonia (PCP) is a frequent cause of pneumonia among human immunodeficiency virus (HIV)-infected patients. Little is known, however, about the role played by humoral immunity to control the infection. This study was undertaken to elucidate the role played by local antibodies. Bronchoalveolar lavage (BAL) fluids from 18 acquired immune deficiency syndrome (AIDS) patients with PCP, 20 HIV-antibody positive patients without PCP, and 20 lung cancer patients were examined for antibodies against P. carinii by the indirect immunofluorescence method. The ratio of albumin concentration in BAL fluid to serum was used to standardize the lavage fluids. Immunoglobulin G (IgG) antibodies against P. carinii occurred less frequently, and immunoglobulin M (IgM) antibodies more frequently, in PCP patients than in other groups. Immunoglobulin A (IgA) antibodies against pneumocysts were found with the same frequency in all three groups, although the median titre was lower among HIV-antibody positive patients without PCP, compared with the other groups. When indexed (antibody titre in BAL fluid x albumin concentration in serum/antibody titre in serum x albumin concentration in BAL fluid) to express locally produced antibodies, IgG indices were significantly higher in HIV-infected patients without PCP, whereas IgM and IgA indices were significantly higher in PCP patients. These findings suggest that the local IgG response is impaired in patients with PCP, whereas the local IgA and, to some extent, the IgM responses are preserved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005248     DOI: 10.1183/09031936.94.07040679

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Decreased production of local immunoglobulin A to Pneumocystis carinii in bronchoalveolar lavage fluid from human immunodeficiency virus-positive patients.

Authors:  A Jalil; P Moja; C Lambert; M Perol; L Cotte; J M Livrozet; A Boibieux; J M Vergnon; F Lucht; R Tran; C Contini; C Genin
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Sangita P Patil; Jan Kristoff; Marianne Bryan; Ronald C Montelaro; Alison Morris; Karen A Norris
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

4.  Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia.

Authors:  T Bauer; S Ewig; E Hasper; J K Rockstroh; B Lüderitz
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

5.  Pneumocystis carinii-induced activation of the respiratory burst in human monocytes and macrophages.

Authors:  A L Laursen; B Møller; J Rungby; C M Petersen; P L Andersen
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

6.  Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.

Authors:  Heather M Kling; Karen A Norris
Journal:  J Infect Dis       Date:  2016-01-27       Impact factor: 5.226

7.  Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.

Authors:  Robert J Blount; Kieran R Daly; Serena Fong; Emily Chang; Katherine Grieco; Meredith Greene; Stephen Stone; John Balmes; Robert F Miller; Peter D Walzer; Laurence Huang
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.